Cite
Adjei-Sowah E, Peng Y, Weeks J, et al. Development of Bisphosphonate-Conjugated Antibiotics to Overcome Pharmacodynamic Limitations of Local Therapy: Initial Results with Carbamate Linked Sitafloxacin and Tedizolid. Antibiotics (Basel). 2021;10(6)doi: 10.3390/antibiotics10060732.
Adjei-Sowah, E., Peng, Y., Weeks, J., Jonason, J. H., de Mesy Bentley, K. L., Masters, E., Morita, Y., Muthukrishnan, G., Cherian, P., Hu, X. E., McKenna, C. E., Ebetino, F. H., Sun, S., Schwarz, E. M., & Xie, C. (2021). Development of Bisphosphonate-Conjugated Antibiotics to Overcome Pharmacodynamic Limitations of Local Therapy: Initial Results with Carbamate Linked Sitafloxacin and Tedizolid. Antibiotics (Basel, Switzerland), 10(6), . https://doi.org/10.3390/antibiotics10060732
Adjei-Sowah, Emmanuela, et al. "Development of Bisphosphonate-Conjugated Antibiotics to Overcome Pharmacodynamic Limitations of Local Therapy: Initial Results with Carbamate Linked Sitafloxacin and Tedizolid." Antibiotics (Basel, Switzerland) vol. 10,6 (2021). doi: https://doi.org/10.3390/antibiotics10060732
Adjei-Sowah E, Peng Y, Weeks J, Jonason JH, de Mesy Bentley KL, Masters E, Morita Y, Muthukrishnan G, Cherian P, Hu XE, McKenna CE, Ebetino FH, Sun S, Schwarz EM, Xie C. Development of Bisphosphonate-Conjugated Antibiotics to Overcome Pharmacodynamic Limitations of Local Therapy: Initial Results with Carbamate Linked Sitafloxacin and Tedizolid. Antibiotics (Basel). 2021 Jun 17;10(6). doi: 10.3390/antibiotics10060732. PMID: 34204351; PMCID: PMC8235690.
Copy
Download .nbib